Although CPSF6 played roles in aggressive breast cancer behavior and exhibited a novel CPSF6-RARG fusion variant in acute myeloid leukemia patients (Binothman et al., 2017; Zhang et al., 2020), the role of CPSF6 in GC is still unknown. Here, RARG is linked to breast carcinoma.